Ribonucleotide reductase, a novel drug target for gonorrhea.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
09 02 2022
Historique:
received: 11 02 2021
accepted: 08 02 2022
pubmed: 10 2 2022
medline: 18 3 2022
entrez: 9 2 2022
Statut: epublish

Résumé

Antibiotic-resistant

Identifiants

pubmed: 35137690
doi: 10.7554/eLife.67447
pii: 67447
pmc: PMC8865847
doi:
pii:

Substances chimiques

Anti-Bacterial Agents 0
Deoxyadenine Nucleotides 0
Pyridines 0
2,4-dihydroxypyridine 626-03-9
Ribonucleotide Reductases EC 1.17.4.-
2'-deoxyadenosine triphosphate K8KCC8SH6N

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM126982
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : Wellcome Trust
ID : 097753
Pays : United Kingdom

Informations de copyright

© 2022, Narasimhan et al.

Déclaration de conflit d'intérêts

JN, SL, SJ, AG, JW, MA, GC, JH, MD, GK, AB was employed by PTC Therapeutics when the work was performed and received salary and compensation during their tenure, KR, TL, CC, CD, JS No competing interests declared

Références

Structure. 2012 Aug 8;20(8):1374-83
pubmed: 22727814
Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21046-51
pubmed: 22160671
Annu Rev Biochem. 2011;80:733-67
pubmed: 21456967
Pharm Res. 2009 Jun;26(6):1504-15
pubmed: 19291372
J Biol Chem. 2018 Jun 29;293(26):10404-10412
pubmed: 29700111
Structure. 1997 Aug 15;5(8):1077-92
pubmed: 9309223
J Struct Biol. 2022 Mar;214(1):107825
pubmed: 34906669
Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9815-20
pubmed: 21628579
Annu Rev Biochem. 2020 Jun 20;89:45-75
pubmed: 32569524
Nat Struct Mol Biol. 2011 Mar;18(3):316-22
pubmed: 21336276
Biochemistry. 2019 Feb 12;58(6):435-437
pubmed: 30586288
Biochemistry. 2003 Dec 16;42(49):14541-52
pubmed: 14661967
BMC Genomics. 2009 Dec 08;10:589
pubmed: 19995434
Bioorg Med Chem Lett. 2017 Nov 15;27(22):5014-5021
pubmed: 29032026
Oncogene. 2015 Apr 16;34(16):2011-21
pubmed: 24909171
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701
Methods Mol Biol. 2019;1997:413-429
pubmed: 31119637
Science. 2020 Apr 24;368(6489):424-427
pubmed: 32217749
J Med Chem. 2018 May 24;61(10):4456-4475
pubmed: 29727185
Nucleic Acids Res. 2006;34(15):e104
pubmed: 16936317
DNA Repair (Amst). 2012 May 1;11(5):480-7
pubmed: 22417940
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Prog Biophys Mol Biol. 2001 Nov;77(3):177-268
pubmed: 11796141
MMWR Surveill Summ. 2016 Jul 15;65(7):1-19
pubmed: 27414503
Antimicrob Agents Chemother. 2016 May 23;60(6):3662-8
pubmed: 27044551
Elife. 2016 Jan 12;5:e07141
pubmed: 26754917
Elife. 2018 Feb 20;7:
pubmed: 29460780
Front Microbiol. 2013 Aug 27;4:255
pubmed: 23986757
Biochem J. 2017 May 16;474(11):1823-1836
pubmed: 28512250
J Antimicrob Chemother. 2016 Nov;71(11):3096-3108
pubmed: 27432602
Z Med Mikrobiol Immunol. 1971;156(2):154-8
pubmed: 5554812
Antimicrob Agents Chemother. 1999 May;43(5):1129-36
pubmed: 10223925
Nat Rev Drug Discov. 2013 Dec;12(12):963
pubmed: 24232373
J Biol Chem. 2006 Sep 22;281(38):27705-11
pubmed: 16861739
Biochemistry. 2003 Sep 2;42(34):10071-83
pubmed: 12939135
Biochemistry. 2020 Apr 14;59(14):1442-1453
pubmed: 32186371
J Clin Microbiol. 2005 Sep;43(9):4321-7
pubmed: 16145072
Annu Rev Biochem. 2006;75:681-706
pubmed: 16756507
J Bacteriol. 1979 May;138(2):320-3
pubmed: 108255
Proc Natl Acad Sci U S A. 2018 May 15;115(20):E4594-E4603
pubmed: 29712847
Crit Rev Biochem Mol Biol. 2012 Jan-Feb;47(1):50-63
pubmed: 22050358
Antimicrob Agents Chemother. 2003 Mar;47(3):1037-46
pubmed: 12604539

Auteurs

Jana Narasimhan (J)

PTC Therapeutics, Inc, South Plainfield, United States.

Suzanne Letinski (S)

PTC Therapeutics, Inc, South Plainfield, United States.

Stephen P Jung (SP)

PTC Therapeutics, Inc, South Plainfield, United States.

Aleksey Gerasyuto (A)

PTC Therapeutics, Inc, South Plainfield, United States.

Jiashi Wang (J)

PTC Therapeutics, Inc, South Plainfield, United States.

Michael Arnold (M)

PTC Therapeutics, Inc, South Plainfield, United States.

Guangming Chen (G)

PTC Therapeutics, Inc, South Plainfield, United States.

Jean Hedrick (J)

PTC Therapeutics, Inc, South Plainfield, United States.

Melissa Dumble (M)

PTC Therapeutics, Inc, South Plainfield, United States.

Kanchana Ravichandran (K)

Department of Chemistry, Massachusetts Institute of Technology, Cambridge, United States.

Talya Levitz (T)

Department of Biology, Massachusetts Institute of Technology, Cambridge, United States.

Chang Cui (C)

Department of Chemistry and Chemical Biology, Harvard University, Cambridge, United States.

Catherine L Drennan (CL)

Department of Chemistry, Massachusetts Institute of Technology, Cambridge, United States.
Department of Biology, Massachusetts Institute of Technology, Cambridge, United States.
Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, United States.

JoAnne Stubbe (J)

Department of Chemistry, Massachusetts Institute of Technology, Cambridge, United States.
Department of Biology, Massachusetts Institute of Technology, Cambridge, United States.

Gary Karp (G)

PTC Therapeutics, Inc, South Plainfield, United States.

Arthur Branstrom (A)

PTC Therapeutics, Inc, South Plainfield, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH